Targeting liver X receptors in cancer therapeutics

CY Lin, JÅ Gustafsson - Nature Reviews Cancer, 2015 - nature.com
Members of the nuclear receptor superfamily of ligand-dependent transcription factors carry
out vital cellular functions and are highly druggable therapeutic targets. Liver X receptors …

Retinoic acid receptors in acute myeloid leukemia therapy

O di Martino, JS Welch - Cancers, 2019 - mdpi.com
Retinoic acid (RA) signaling pathways regulate fundamental biological processes, such as
cell proliferation, development, differentiation, and apoptosis. Retinoid receptors (RARs and …

Advances in acute myeloid leukemia differentiation therapy: A critical review

AK Abdel-Aziz - Biochemical Pharmacology, 2023 - Elsevier
Acute myeloid leukemia (AML) is characterized by impaired differentiation and indefinite
proliferation of abnormal myeloid progenitors. Although differentiating agents were deemed …

Nuclear receptors: Lipid and hormone sensors with essential roles in the control of cancer development

J Font-Díaz, A Jiménez-Panizo, C Caelles… - Seminars in cancer …, 2021 - Elsevier
Nuclear receptors (NRs) are a superfamily of ligand-activated transcription factors that act as
biological sensors and use a combination of mechanisms to modulate positively and …

Targeting cholesterol homeostasis in hematopoietic malignancies

A Brendolan, V Russo - Blood, The Journal of the American …, 2022 - ashpublications.org
Cholesterol is a vital lipid for cellular functions. It is necessary for membrane biogenesis, cell
proliferation, and differentiation. In addition to maintaining cell integrity and permeability …

LXR agonist treatment of blastic plasmacytoid dendritic cell neoplasm restores cholesterol efflux and triggers apoptosis

A Ceroi, D Masson, A Roggy, C Roumier… - Blood, The Journal …, 2016 - ashpublications.org
Blastic plasmacytoid dendritic cell (PDC) neoplasm (BPDCN) is an aggressive
hematological malignancy with a poor prognosis that derives from PDCs. No consensus for …

[HTML][HTML] Molecular precision medicine: Multi-omics-based stratification model for acute myeloid leukemia

T Wang, S Cui, C Lyu, Z Wang, Z Li, C Han, W Liu… - Heliyon, 2024 - cell.com
Acute myeloid leukemia (AML), as the most common malignancy of the hematopoietic
system, poses challenges in treatment efficacy, relapse, and drug resistance. In this study …

[HTML][HTML] Upregulation of CD11b and CD86 through LSD1 inhibition promotes myeloid differentiation and suppresses cell proliferation in human monocytic leukemia …

J Fang, H Ying, T Mao, Y Fang, Y Lu, H Wang, I Zang… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Abstract LSD1 (Lysine Specific Demethylase1)/KDM1A (Lysine Demethylase 1A), a flavin
adenine dinucleotide (FAD)-dependent histone H3K4/K9 demethylase, sustains oncogenic …

Emerging roles of bexarotene in the prevention, treatment and anti-drug resistance of cancers

D Shen, X Yu, Y Wu, Y Chen, G Li… - Expert Review of …, 2018 - Taylor & Francis
Introduction: Retinoic acid X receptors play key roles in tumor cell proliferation,
differentiation, apoptosis and angiogenesis via transcriptional regulation. Bexarotene is a …

Modulating retinoid-X-receptor alpha (RXRA) expression sensitizes chronic myeloid leukemia cells to imatinib in vitro and reduces disease burden in vivo

BM Rajamani, RSS Illangeswaran… - Frontiers in …, 2023 - frontiersin.org
Introduction: The ligand-activated transcription factors, nuclear hormone receptors (NHRs),
remain unexplored in hematological malignancies except for retinoic acid receptor alpha …